Literature DB >> 11330728

Phenobarbital following phototherapy for Crigler-Najjar syndrome type II with good fetal outcome: a case report.

T Ito1, C Katagiri, S Ikeno, H Takahashi, N Nagata, N Terakawa.   

Abstract

In the presence of severe hyperbilirubinemia in Crigler-Najjar syndrome Type II, a fetus is at risk for kernicterus. A 34-year-old woman, gravida 4, para 1, with Crigler-Najjar syndrome Type II was treated with phenobarbital administration following phototherapy during each of 2 pregnancies. Both infants were healthy and developed normally.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330728     DOI: 10.1111/j.1447-0756.2001.tb01212.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Recommendations for pregnancies in patients with crigler-najjar syndrome.

Authors:  J H Paul Wilson; Maarten Sinaasappel; Fred K Lotgering; Janneke G Langendonk
Journal:  JIMD Rep       Date:  2012-04-22

2.  Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.

Authors:  Lufeng Li; Guohong Deng; Yi Tang; Qing Mao
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

3.  Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report.

Authors:  Samuel Raimundo Fernandes; Carlos Miguel Moura; Beatriz Rodrigues; Luís Araújo Correia; Helena Cortez-Pinto; José Velosa
Journal:  BMC Gastroenterol       Date:  2016-03-11       Impact factor: 3.067

4.  Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia.

Authors:  Lori W E van der Schoor; Henkjan J Verkade; Anna Bertolini; Sanne de Wit; Elvira Mennillo; Eva Rettenmeier; André A Weber; Rick Havinga; Petra Valášková; Jana Jašprová; Dicky Struik; Vincent W Bloks; Shujuan Chen; Andrea B Schreuder; Libor Vítek; Robert H Tukey; Johan W Jonker
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.